Reliable Characterization of Organic & Pharmaceutical Compounds with High Resolution Monochromated EEL Spectroscopy.

EELS TEM amorphous monochromator organic pharmaceutical plasmon loss

Journal

Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357

Informations de publication

Date de publication:
27 Jun 2020
Historique:
received: 28 05 2020
revised: 22 06 2020
accepted: 23 06 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 2 7 2020
Statut: epublish

Résumé

Organic and biological compounds (especially those related to the pharmaceutical industry) have always been of great interest for researchers due to their importance for the development of new drugs to diagnose, cure, treat or prevent disease. As many new API (active pharmaceutical ingredients) and their polymorphs are in nanocrystalline or in amorphous form blended with amorphous polymeric matrix (known as amorphous solid dispersion-ASD), their structural identification and characterization at nm scale with conventional X-Ray/Raman/IR techniques becomes difficult. During any API synthesis/production or in the formulated drug product, impurities must be identified and characterized. Electron energy loss spectroscopy (EELS) at high energy resolution by transmission electron microscope (TEM) is expected to be a promising technique to screen and identify the different (organic) compounds used in a typical pharmaceutical or biological system and to detect any impurities present, if any, during the synthesis or formulation process. In this work, we propose the use of monochromated TEM-EELS, to analyze selected peptides and organic compounds and their polymorphs. In order to validate EELS for fingerprinting (in low loss/optical region) and by further correlation with advanced DFT, simulations were utilized.

Identifiants

pubmed: 32605004
pii: polym12071434
doi: 10.3390/polym12071434
pmc: PMC7408036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union's Horizon 2020 research and innovation programme
ID : 731019 (EUSMI)

Références

Microsc Microanal. 2002 Apr;8(2):134-8
pubmed: 12533242
Langmuir. 2016 Jul 26;32(29):7411-9
pubmed: 27419264
Micron. 2003;34(3-5):219-25
pubmed: 12895493
Pharm Res. 2011 Sep;28(9):2311-26
pubmed: 21607778
ISRN Pharm. 2012;2012:195727
pubmed: 22830056
Microsc Microanal. 2015 Apr;21(2):459-71
pubmed: 25510245
Pharm Res. 2001 Jun;18(6):859-66
pubmed: 11474792
Mol Pharm. 2016 Mar 7;13(3):1123-36
pubmed: 26859046
Anal Chem. 2019 Jun 4;91(11):7411-7417
pubmed: 31050887
J Electron Microsc Tech. 1988 Feb;8(2):193-200
pubmed: 3246607
Ultramicroscopy. 2010 Jun;110(7):866-76
pubmed: 20447768
Phys Rev Lett. 1996 Oct 28;77(18):3865-3868
pubmed: 10062328
Eur J Pharm Biopharm. 2009 Jan;71(1):23-37
pubmed: 18715549
Microsc Microanal. 2016 Jun;22(3):706-16
pubmed: 26868876
Ultramicroscopy. 2017 Sep;180:115-124
pubmed: 28377217
J Chem Phys. 2020 Feb 21;152(7):074101
pubmed: 32087668
AAPS J. 2012 Sep;14(3):380-8
pubmed: 22434258
J Pharm Sci. 2010 Sep;99(9):4072-83
pubmed: 20665849
Ultramicroscopy. 2006 Jan;106(2):130-45
pubmed: 16112807
Micron. 2006;37(5):396-402
pubmed: 16551502
Micron. 2007;38(1):12-28
pubmed: 16914318
J Pharm Sci. 2011 Nov;100(11):4888-95
pubmed: 21656518
J Pharm Sci. 1999 Mar;88(3):297-301
pubmed: 10052986
Acta Crystallogr A Found Adv. 2016 Mar;72(Pt 2):236-42
pubmed: 26919375
Chemistry. 2013 Jun 10;19(24):7874-82
pubmed: 23592444
ACS Cent Sci. 2019 Aug 28;5(8):1315-1329
pubmed: 31482114
J Pharm Sci. 1969 Aug;58(8):911-29
pubmed: 4899118
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2180-4
pubmed: 12604798
J Pharm Sci. 2012 Jun;101(6):2066-73
pubmed: 22388948
Molecules. 2015 Oct 15;20(10):18759-76
pubmed: 26501244
Chemistry. 2013 Jun 10;19(24):7883-8
pubmed: 23592497
Ultramicroscopy. 2007 Jun-Jul;107(6-7):507-13
pubmed: 17234347
J Microsc. 1995 Jan;177(Pt 1):18-30
pubmed: 7897645

Auteurs

Partha Pratim Das (PP)

NanoMegas SPRL, Boulevard Edmond Machtens 79, B1080 Brussels, Belgium.
Electron Crystallography Solutions SL, Calle Orense 8, 28020 Madrid, Spain.

Giulio Guzzinati (G)

EMAT, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.

Catalina Coll (C)

LENS-MIND, Department of Electronics and Biomedical Engineering, Universitat de Barcelona, 08028 Barcelona, Spain.
Institute of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain.

Alejandro Gomez Perez (A)

NanoMegas SPRL, Boulevard Edmond Machtens 79, B1080 Brussels, Belgium.

Stavros Nicolopoulos (S)

NanoMegas SPRL, Boulevard Edmond Machtens 79, B1080 Brussels, Belgium.

Sonia Estrade (S)

LENS-MIND, Department of Electronics and Biomedical Engineering, Universitat de Barcelona, 08028 Barcelona, Spain.
Institute of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain.

Francesca Peiro (F)

LENS-MIND, Department of Electronics and Biomedical Engineering, Universitat de Barcelona, 08028 Barcelona, Spain.
Institute of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain.

Johan Verbeeck (J)

EMAT, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.

Aikaterini A Zompra (AA)

Department of Pharmacy, University of Patras, 26504 Patras, Greece.

Athanassios S Galanis (AS)

NanoMegas SPRL, Boulevard Edmond Machtens 79, B1080 Brussels, Belgium.

Classifications MeSH